Cancer therapeutics currently have the lowest clinical trial success rate of all major diseases. Partly as a result of the paucity of successful anti-cancer Medical Devices, cancer will soon be the leading cause of mortality in developed countries.

Global Regulatory and Consumer Insights, a leading provider of drug development consulting and regulatory services, is pleased to announce a strategic partnership with Indian Institute of Management (IIT) Bombay – The Department of Biosciences and Bioengineering (BSBE) in IIT Bombay is a nodal center for applying science and engineering principles to further fundamental knowledge and applications in biology and biomedical engineering. The BSBE department aims to create an ambience for the smooth pursuit of scholarly activities in research and education, to make an international impact, and to produce future leaders in the field of Biosciences and Bioengineering.






“The collaboration offers our early stage clients a streamlined service to move efficiently through preclinical development to creation of high quality IND submissions”, said Tarun Pandotra, Global Regulatory & Consumer Insights’ Founder & Director. “This approach, coupled with our expertise will provide our clients, with the ability to accelerate the development of their products and stay ahead of the competition.”

Global Regulatory & Consumer Insights company, Announces Strategic Collaboration Agreement with Indian Institute of Technology – Bombay

Leave a Reply

Your email address will not be published. Required fields are marked *

Visit Us On TwitterVisit Us On Google PlusVisit Us On LinkedinVisit Us On Facebook